Unlock instant, AI-driven research and patent intelligence for your innovation.

Uses of aromatic nitrovinyl compounds

A technology for compounds and uses, applied in the directions of active ingredients of nitro compounds, medical preparations containing active ingredients, and drug combinations, etc.

Active Publication Date: 2021-08-17
XIAMEN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although ATRA and Arsenic can produce good therapeutic effects on most APL patients, they still have significant limitations in the treatment of APL

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Uses of aromatic nitrovinyl compounds
  • Uses of aromatic nitrovinyl compounds
  • Uses of aromatic nitrovinyl compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0263] Example 1. Z-10 induces differentiation and apoptosis of APL cells

[0264] 1. NB4 cells (a kind of APL cells) were treated with DMSO, ATRA (1 μM), Arsenic (1 μM) or Z-10 (3 μM) for two days respectively, then labeled with anti-CD11b antibody, counted by flow cytometry, and the results were as follows figure 1 As shown in B, the red curve in the figure is the DMSO control group, and the green curve is the compound treatment group.

[0265] figure 1 B shows that compounds ATRA, Arsenic and Z-10 are all able to induce the differentiation of NB4 cells.

[0266] 2. NB4 cells were treated with ATRA (1 μM), Arsenic (1 μM) or Z-10 (1 μM, 2 μM or 3 μM) for 36 hours, then double-stained with Annexin V-FITC and Propidium iodide (PI), and analyzed by flow cytometry analysis, the result is figure 1 C shown.

[0267] figure 1 C shows:

[0268] (1) The ratios of early apoptotic cells and late apoptotic cells in DMSO group were 2.82% and 1.39%, respectively. And the proportion ...

Embodiment 2

[0275] Example 2. Z-10 can induce the cleavage and degradation of PML-RARα protein

[0276] 1. After NB4 cells were treated with Z-10 (5μM) for 2h, 4h or 8h, the cell lysate was collected and detected by western blot with anti-RARα antibody to determine the expression of PML-RARα. The results are shown in 2A.

[0277] figure 2 A shows that after NB4 cells were treated with Z-10, the band of PML-RARα became lighter as time went on, while the band of the cleaved fragment of PML-RARα became deeper. This shows that Z-10 can time-dependently induce the cleavage and degradation of PML-RARα.

[0278]2. After NB4 cells were treated with 2 μM, 4 μM or 8 μM Z-10 for 4 hours, the cell lysate was collected and detected by western blot with anti-RARα antibody to determine the expression of PML-RARα, the results are shown in 2B.

[0279] figure 2 B shows that after NB4 cells were treated with Z-10, the higher the concentration of Z-10, the lighter the band of PML-RARα, and the darker t...

Embodiment 3

[0289] Example 3. RXRα stabilizes PML-RARα, while Z-10 induces PML-RARα degradation by inhibiting the interaction between RXRα and PML-RARα

[0290] 1. Three days after NB4 cells were infected with shRXRα lentivirus, the expression of each protein was detected by western blot, the results are as follows image 3 As shown in A.

[0291] image 3 A shows that, compared with the control group, when the expression of RXRα in NB4 cells was inhibited by shRXRα, the expression levels of PML-RARα and RARα were significantly reduced. This shows that RXRα can stabilize PML-RARα.

[0292] 2. Transfect the expression plasmids of PML-RARα or PML-RARα and Myc-RXRα in Cos7 cells respectively, treat with Z-10 (5μM) for 4h after 24h, then collect the cell lysate and detect it with anti-Myc antibody co-immunoprecipitation The interaction of RXRα and PML-RARα was determined as image 3 Shown in B.

[0293] image 3 B shows that in the test group co-transfected with PML-RARα and Myc-RXRα, b...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The application relates to the use of aromatic nitrovinyl compounds. Specifically, the application relates to the use of the compound shown in formula I, its stereoisomer or pharmaceutically acceptable salt for regulating the activity (such as transcriptional activity) of RXRα, or for preparing the activity (such as transcriptional activity) of regulating RXRα ) drug use:

Description

technical field [0001] This application relates to the fields of medicine and biology. In particular, the present application relates to the use of aromatic nitrovinyl compounds. The present application also relates to the use of compounds represented by formula I. The present application also relates to the use of the compound represented by formula I in the preparation of medicines for preventing or treating diseases related to nuclear receptor RXRα (such as leukemia, especially acute promyelocytic leukemia). Background technique [0002] Acute promyelocytic leukemia (APL) is a subtype of myeloid leukemia, which is acute myeloid leukemia M3 type, accounting for about 15% of acute myeloid leukemia. The clinical manifestations of this type of leukemia are dangerous, and hemorrhage is prone to occur during the onset and treatment, leading to death. APL is mainly a type of leukemia caused by chromosomal translocations. The World Health Organization requires that the diagno...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/09A61K31/085A61K31/04A61P35/02
CPCA61K31/04A61K31/085A61K31/09
Inventor 周虎曾志平张晓坤许琳张伟东任高昂尚策
Owner XIAMEN UNIV